SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-034255
Filing Date
2022-12-02
Accepted
2022-12-02 13:30:01
Documents
44
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 804908
2 ex31.htm EX-31 17955
3 ex32.htm EX-32 6772
  Complete submission text file 0001493152-22-034255.txt   3747563

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clcs-20220630.xsd EX-101.SCH 28362
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clcs-20220630_cal.xml EX-101.CAL 39815
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clcs-20220630_def.xml EX-101.DEF 150890
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clcs-20220630_lab.xml EX-101.LAB 262870
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clcs-20220630_pre.xml EX-101.PRE 208285
38 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 509553
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 221441306
SIC: 2834 Pharmaceutical Preparations